Pharmafile Logo

Boost Publication Collaboration Virtually – Engaging Your Advisors Creatively

Tired of traditional advisory board limitations? Explore innovative ways to engage your KOLs, HCPs, and MSLs in our new series! Learn how to co-create impactful publications virtually in our first tip of this top 10 tips series.

Discover how to revolutionize publication planning, development, and collaboration in the digital age. Empower your KOLs, DOLs, MSLs, HCPs, and other geographically dispersed stakeholders to co-create impactful publications, including peer-reviewed articles, guidelines, and educational materials. Learn how asynchronous and synchronous tools streamline every step of the process, from idea conception to final dissemination, resulting in faster results and higher engagement rates compared to traditional in-person meetings.

  1. Learn how to leverage digital solutions to enhance collaboration on publications, including:
  • Co-creating peer-reviewed articles and guidelines
  • Streamlining literature reviews and draft development
  • Utilizing asynchronous and synchronous tools for efficient communication
  • Increasing engagement with geographically dispersed advisors

Explore how the Impetus InSite Platform® can transform your publication process.

For more creative ways to engage your advisors, visit: https://www.impetusdigital.com/2019/11/15/top-10-creative-ways-to-engage-your-advisors/

Learn more about Impetus Digital’s solutions: www.impetusdigital.com

Schedule a consultation: https://meetwithimpetus.com/

Stay connected:

#VirtualCollaboration #PublicationPlanning #AdvisoryBoards #DigitalEngagement #LifeSciences #Pharma #ImpetusDigital

This content was provided by Impetus Digital

Company Details

 Latest Content from  Impetus Digital 

Top-5 Trends in Virtual KOL Engagement

Register now for one of our upcoming webinars (February 26-28)

Engaging with Different Perspectives – Top 10 Most Important Advisor Questions

In this quick clip, we highlight a vital tip from our 'Top 10 Most Important Advisor Questions' – essential for enhancing your virtual collaboration strategies in Pharma and Life Sciences....

Patient Advocate Engagement: A Customer Story

Learn how our client executed a series of 3 virtual touchpoints with 5 rare disease patient advocates to:- Develop a better understanding of the current treatment landscape and lived patient...

Tailored Marketing Strategies for Pharma – Top 10 Most Important Advisor Questions

In this video, we explore another crucial aspect of advisor questions when developing your virtual advisory board touchpoints – a key component for success in today's diverse healthcare landscape. 7....

Trends in Virtual Collaboration

Join us for a look at the top-5 emerging virtual collaboration trends...

Advisor Questions on Potential Data or Knowledge Gaps

As part of our top 10 most important advisor questions that every brand team should keep in mind when designing virtual advisory board touchpoints, here's another one to keep in...

On a journey to diverse, inclusive, and more efficient rare disease trials

Although orphan drugs represent a sizeable portion of new drug approvals, most rare diseases still lack effective treatment. Even more so than for other conditions, rare disease management contains large care...

Versatility! Top 10 benefits of virtual advisory boards

Here's another great tip on why the benefits of virtual advisory boards are superior to in-person and hybrid advisory boards. #10. Versatility! Another major advantage of using a virtual platform...

Clinical Trials Investigator and Patient Engagement Planning: A Customer Story

In the early lead-up to our client’s multi-center Rare Disease Phase 3 Clinical Trial, they first conducted an internal engagement planning Longitudinal Expert Engagement Plan™ (LEEP™) to conduct an informal...

New Playbook Alert: Virtual Patient Engagement

Authentic patient engagement and insight-gathering are becoming must-haves in Pharma. However, multiple obstacles remain before patient-centricity becomes more than a buzzword. In our latest playbook, we take a deep dive...